Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of “Hold” from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has been assigned an average rating of “Hold” from the twelve research firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $76.6667.

Several brokerages have recently commented on HSIC. Barrington Research decreased their price objective on shares of Henry Schein from $86.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 6th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Stifel Nicolaus restated a “hold” rating and set a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Robert W. Baird restated a “neutral” rating and set a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th.

Henry Schein Stock Up 0.1%

HSIC opened at $67.92 on Thursday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market capitalization of $8.24 billion, a PE ratio of 21.91, a PEG ratio of 2.24 and a beta of 0.86. The firm’s 50 day simple moving average is $68.70 and its two-hundred day simple moving average is $69.28.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently bought and sold shares of the stock. CYBER HORNET ETFs LLC bought a new stake in Henry Schein in the 2nd quarter valued at $25,000. MUFG Securities EMEA plc bought a new stake in Henry Schein in the 2nd quarter valued at $27,000. Investment Management Corp VA ADV bought a new stake in Henry Schein in the 4th quarter valued at $32,000. Rakuten Securities Inc. bought a new stake in Henry Schein in the 1st quarter valued at $34,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Henry Schein in the 2nd quarter valued at $43,000. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.